DaVita Kidney Care Outperforms All Dialysis Providers in Quality Incentive Program

  DaVita Kidney Care Outperforms All Dialysis Providers in Quality Incentive
                                   Program

CMS data shows comprehensive, holistic care at DaVita improves patient
outcomes

PR Newswire

DENVER, June 24, 2014

DENVER, June 24, 2014 /PRNewswire-USNewswire/ -- DaVita Kidney Care, a
division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider
of kidney care services, today announced its 2014 end stage renal disease
(ESRD) Quality Incentive Program (QIP) results from the Centers for Medicare
and Medicaid Services (CMS). DaVita outperformed other kidney care providers
in every category, with 98.4 percent of the company's centers ranking in the
top clinical performance tier. The full report can be downloaded at CMS.gov.

www.davitahealthcarepartners.com.

"The QIP results demonstrate that DaVita's holistic, comprehensive care
approach works," said DaVita HealthCare Partners CEO Kent Thiry. "As part of
our culture of continuous improvement, we are working with members of the
kidney care community and CMS to improve care for our patients."

DaVita also distinguished itself in reducing the proportion of low-performing
centers in rural and low-income counties. Since QIP's inception in 2012,
DaVita has achieved a 21 percent reduction in rural and low incomecenters
that missed the top clinical tier while the rest of the industry saw a 24
percent increase.

QIP is part of Medicare's ESRD quality incentive program aimed at improving
the quality of care provided to Medicare patients. It was designed in part to
be the nation's first pay-for-performance quality incentive program, mandated
through a series of reforms passed into law in 2008. CMS describes QIP as a
"first-of-its-kind program [that] provides the ESRD community with the
opportunity to enhance the overall quality of care that ESRD patients receive
as they battle this devastating disease."

"We value the relationship we have with CMS and legislators across the
country," said DaVita Group Vice President LeAnne Zumwalt. "Having a
government partner committed to helping reduce hospitalizations and improve
survival rates is important to us, our patients and their families."

QIP takes three clinical areas into account: urea reduction ratio (URR),
anemia management and vascular access management. URR determines how
effectively a dialysis treatment removes waste from the body and is commonly
noted as a percentage. At the end of 2012, DaVita reported that only 0.6
percent of its patients – an all-time low – were below the 65 percent
baseline.

In treating anemia, a common complication for ESRD patients, hemoglobin must
be kept below 12 g/dl. In 2012, only one quarter of one percent of DaVita
patients' hemoglobin levels were at or over 12 g/dl, compared to the industry
average of .69 percent of patients at or above 12 g/dl.

Since the inception of CathAway^TM, a proprietary program designed to
transition patients from central venous catheters (CVC) to arteriovenous (AV)
fistulas to reduce the risk of hospitalization from infections and blood
clots, DaVita has driven a 30 percent reduction in catheter use in patients
who have been dialyzing for 90 days or more. DaVita patients were at an
all-time low CVC rate of 9.9 percent and an all-time high AV fistula rate of
64 percent at the end of 2012. DaVita results also showed over an 11 percent
reduction in gross mortality rates since 2010, representing thousands of lives
saved.

DaVita has a holistic approach to kidney care that is patient-centric and
addresses a range of health factors to deliver quality treatment. Since 2000,
DaVita has demonstrated improved clinical outcomesin several critical areas,
including vascular access, survival rates, bone and mineral metabolism
management, dialysis adequacy and preventative care such as immunizations.

DaVita and CathAway are trademarks or registered trademarks of DaVita
HealthCare Partners Inc.

AboutDaVita Kidney Care
DaVita Kidney Careis a division of DaVita HealthCare Partners Inc., a Fortune
500® company that, through its operating divisions, provides a variety of
health care services to patient populations throughout the United States and
abroad. A leading provider of dialysis services in the United States, DaVita
Kidney Caretreats patients with chronic kidney failure and end stage renal
disease.DaVita Kidney Carestrives to improve patients' quality of life by
innovating clinical care, and by offering integrated treatment plans,
personalized care teams and convenient health-management services. As of March
31, 2014,DaVita Kidney Careoperated or provided administrative services at
2,098 outpatient dialysis centers located in the United States serving
approximately 165,000patients. The company also operated 75 outpatient
dialysis centers located in 10 countries outside the United States.DaVita
Kidney Caresupports numerous programs dedicated to creating positive,
sustainable change in communities around the world. The company's leadership
development initiatives and social responsibility efforts have been recognized
by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information,
please visitDaVita.com.

Media:
Vince Hancock
Vince.Hancock@DaVita.com
(303) 876-6618

Logo - http://photos.prnewswire.com/prnh/20140318/DC85712LOGO

SOURCE DaVita
 
Press spacebar to pause and continue. Press esc to stop.